EDITORIAL
Published on 29 Jan 2026
Editorial: Next-generation PROTACs in oncology and beyond: exploring therapeutic targets and their degraders
doi 10.3389/fphar.2026.1787837
- 1,900 views
- Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
- Research Topics
- Next-Generation PROTACs in Oncology and Beyond: Exploring Therapeutic Targets and Their Degraders
Next-Generation PROTACs in Oncology and Beyond: Exploring Therapeutic Targets and Their Degraders
5,865
Total downloads
35k
Total views and downloads
Articles
REVIEW
Published on 12 Aug 2025
Indoleamine 2,3-dioxygenase 1 in cancer immunotherapy: from small-molecule inhibition to PROTAC-mediated degradation
doi 10.3389/fphar.2025.1640073
- 6,258 views
- 12 citations
ORIGINAL RESEARCH
Published on 15 Apr 2025
YX-112, a novel celastrol-derived PROTAC, inhibits the development of triple-negative breast cancer by targeting the degradation of multiple proteins
doi 10.3389/fphar.2025.1571135
- 3,618 views
- 5 citations
REVIEW
Published on 26 Feb 2025
Unleashing the power of peptides in prostate cancer immunotherapy: mechanism, facts and perspectives
doi 10.3389/fphar.2025.1478331
- 13,147 views
- 6 citations
REVIEW
Published on 25 Feb 2025
MLKL as an emerging machinery for modulating organelle dynamics: regulatory mechanisms, pathophysiological significance, and targeted therapeutics
doi 10.3389/fphar.2025.1512968
- 6,502 views
- 18 citations
